Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | Cherry Hill, NJ, United States | Makes it, tests it and labels it | No problems foundMay 13, 2026 · 18 inspections |
Recalls
- Jul 11, 2022 · Class II · Hikma Pharmaceuticals USA Inc.
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Lots: Lot # 070088, exp. date 07/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lorazepam: every company that makes it
- Form
- injection, intramuscular; intravenous
- Strength
- 2.0 mg per 1 mL
- Approval
- NDA NDA018140
- On the market since
- Jul 25, 1980
- Package NDCs
0641-6048-010641-6048-25- Official label
- DailyMed (National Library of Medicine), updated Apr 10, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?